John Landry - 27 Feb 2024 Form 4 Insider Report for VAPOTHERM INC

Role
SVP & Chief Financial Officer
Signature
/s/ James Lightman, as Attorney In Fact
Issuer symbol
N/A
Transactions as of
27 Feb 2024
Net transactions value
$0
Form type
4
Filing time
29 Feb 2024, 17:13:16 UTC
Previous filing
04 Oct 2023
Next filing
24 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VAPO Common Stock 68,918 27 Feb 2024 Direct F1
holding VAPO Common Stock 1,693 27 Feb 2024 By Roth IRA I F2
holding VAPO Common Stock 425 27 Feb 2024 By Roth IRA II F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VAPO Stock Option (right to buy) Disposed to Issuer -3,503 -100% 0 27 Feb 2024 Common Stock 3,503 $137.20 Direct F3, F4
transaction VAPO Stock Option (right to buy) Award +3,503 3,503 27 Feb 2024 Common Stock 3,503 $0.9150 Direct F3, F4
transaction VAPO Stock Option (right to buy) Disposed to Issuer -3,250 -100% 0 27 Feb 2024 Common Stock 3,250 $97.28 Direct F3, F4
transaction VAPO Stock Option (right to buy) Award +3,250 3,250 27 Feb 2024 Common Stock 3,250 $0.9150 Direct F3, F4
transaction VAPO Stock Option (right to buy) Disposed to Issuer -9,943 -100% 0 27 Feb 2024 Common Stock 9,943 $97.28 Direct F3, F4
transaction VAPO Stock Option (right to buy) Award +9,943 9,943 27 Feb 2024 Common Stock 9,943 $0.9150 Direct F3, F4
transaction VAPO Stock Option (right to buy) Disposed to Issuer -2,150 -100% 0 27 Feb 2024 Common Stock 2,150 $214.88 Direct F4, F5
transaction VAPO Stock Option (right to buy) Award +2,150 2,150 27 Feb 2024 Common Stock 2,150 $0.9150 Direct F4, F5
transaction VAPO Stock Option (right to buy) Disposed to Issuer -3,062 -100% 0 27 Feb 2024 Common Stock 3,062 $165.68 Direct F4, F6
transaction VAPO Stock Option (right to buy) Award +3,062 3,062 27 Feb 2024 Common Stock 3,062 $0.9150 Direct F4, F6
transaction VAPO Stock Option (right to buy) Disposed to Issuer -6,625 -100% 0 27 Feb 2024 Common Stock 6,625 $25.28 Direct F4, F7
transaction VAPO Stock Option (right to buy) Award +6,625 6,625 27 Feb 2024 Common Stock 6,625 $0.9150 Direct F4, F7
transaction VAPO Stock Option (right to buy) Disposed to Issuer -6,834 -100% 0 27 Feb 2024 Common Stock 6,834 $21.60 Direct F4, F8
transaction VAPO Stock Option (right to buy) Award +6,834 6,834 27 Feb 2024 Common Stock 6,834 $0.9150 Direct F4, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 625 shares that were purchased under the Vapotherm, Inc. 2018 Employee Stock Purchase Plan, 23,845 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan and 10,760 shares held by the reporting person's Roth IRA.
F2 The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3 This option, which was previously subject to four-year vesting, is fully vested.
F4 The transactions reported herein reflect a stock option repricing effective February 27, 2024 pursuant to which the exercise price of the repriced options was amended to reduce the exercise price to $0.915 per share, the closing price of the Issuer's common stock on February 27, 2024. There is no change to the expiration dates or the vesting schedule of the repriced options.
F5 This option vested as to 25% of the underlying shares on January 1, 2022, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.
F6 This option vested as to 25% of the underlying shares on January 1, 2023, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.
F7 This option vested as to 25% of the underlying shares on January 1, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.
F8 This option vested as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.

Remarks:

On August 18, 2023, a 1-for-8 reverse split of the common stock of Vapotherm, Inc. occurred resulting in a decrease in the number of shares held by the Reporting Person. In addition, proportionate adjustments to the Reporting Person's outstanding equity awards, including the exercise price and number of shares exercisable under the option awards listed in Table II to this Form 4, have been made to reflect the 1-for-8 reverse stock split.